ALLR
Allarity Therapeutics
ALLR
ALLR
8 hedge funds and large institutions have $86.1K invested in Allarity Therapeutics in 2025 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
+3
Holders Change %
+60%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
2
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
$31.8K |
| 2 |
Morgan Stanley
New York
|
$21.8K |
| 3 |
CCM
Corsair Capital Management
New York
|
$18.7K |
| 4 |
Barclays
London,
United Kingdom
|
$9K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
$4.41K |
Top Sellers
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
$0 |
| 2 |
Goldman Sachs
New York
|
$0 |
| 3 |
Citigroup
New York
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Geode Capital Management
Boston,
Massachusetts
| $31.8K | +$31.8K | +33,921 | New |
|
|
2
Morgan Stanley
New York
| $21.8K | +$21.8K | +23,311 | New |
|
|
CCM
3
Corsair Capital Management
New York
| $18.7K | +$18.7K | +20,000 | New |
|
|
4
Barclays
London,
United Kingdom
| $9K | +$9K | +10,078 | New |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $4.41K | +$411 | +439 | +10% |
|
6
UBS Group
Zurich,
Switzerland
| $281 | +$281 | +300 | New |
|
7
Bank of America
Charlotte,
North Carolina
| $36 | +$15 | +16 | +73% |
|
8
Osaic Holdings
Scottsdale,
Arizona
| $6 | +$6 | +7 | New |
|
|
SCM
9
Stonepine Capital Management
Bend,
Oregon
| – | -$78.7K | -67,289 | Closed |
|
|
10
Goldman Sachs
New York
| – | -$24.1K | -20,616 | Closed |
|
|
11
Citigroup
New York
| – | -$14.4K | -12,294 | Closed |
|